Apr 9, 2019
Biosimilars Market report analyzed by supply demand with global trends analysis and this report shows the current market status with industry chain structure of Biosimilars industry.

Pune, India - April 8, 2019 /MarketersMedia/ —
The “Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing Type (In-house, Contract), Disease (Oncology, Autoimmune) - Global Forecast to 2023” report presents an in-depth assessment of the Biosimilars including enabling technologies, key trends, market drivers, challenges, deployment case studies, standardization, opportunities, future roadmap, value chain, Top key player profiles and strategies. The report also presents market size forecasts from 2018 till 2023.
Get Here Free Sample Research Report of “Biosimilars Market” at https://www.reportsnreports.com/contacts/requestsample.aspx?name=270786
The Biosimilars Market is expected to reach US$ 23.63 Billion by 2023 from US$ 5.95 Billion in 2018, at a CAGR of 31.7%. Factors driving the growth of this market include increasing demand for biosimilar drugs due to their cost-effectiveness, rising incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.
“The recombinant glycosylated protein segment is anticipated to grow at the fastest growth rate during the forecast period.”
The Biosimilars market by product is categorized into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant glycosylated proteins segment is expected to register the highest CAGR during the forecast period. The factors driving the market for glycosylated proteins are the broad therapeutic area of these proteins; presence of biosimilar versions of monoclonal antibodies at lower prices compared to reference products; numerous biologic drugs underclass monoclonal antibody, follitropin, and erythropoietin going off-patent; and numerous products in the pipeline.
By type of manufacturing, the biosimilars market is segmented into in-house manufacturing and contract manufacturing. The contract manufacturing segment is expected to grow at the highest CAGR during the forecast period. CMOs provide cost-saving benefits to companies in terms of facilities, equipment, and labor costs.
“Asia is estimated to register the highest CAGR during the study period.”
On the basis of region, the biosimilars market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Many Asian countries such as India, China, South Korea, and Japan have emerged as potential markets for biosimilars. Many emerging economies in the region are also establishing biosimilar pathways. Moreover, leading market players are outsourcing manufacturing and R&D activities to countries in the Asia Pacific region due to the availability of highly skilled resources at lower costs.
Browse 176 Tables, 37 Figures, 10 Companies, spread across 181 pages available at https://www.reportsnreports.com/purchase.aspx?name=270786
Report Highlights:
• To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
• To forecast the size of the market with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To define, describe, segment, and forecast the biosimilars market by product, type of manufacturing, disease, and region
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To track and analyze competitive developments such as collaborations, regulatory approvals, partnerships, acquisitions, and product launches in the biosimilars market
Target Audience for Biosimilars Market: Private equity companies and venture capital firms, Biopharmaceutical drug manufacturers (biosimilars and biologics), Healthcare service providers (hospitals and independent physicians), Health insurance payers, Research and consulting service firms, Contract research organizations (CROs), Pharmaceutical and medical associations, Contract manufacturing organizations (CMOs).
Ask Discount @ https://www.reportsnreports.com/contacts/discount.aspx?name=270786
Top Companies in the Biosimilars Market inclure are Pfizer (US), Sandoz (Germany), Teva Pharmaceuticals (Israel), Amgen (US), Biocon (India), Dr. Reddy’s Laboratories (India), Celltrion (South Korea).
Competitive Landscape of Biosimilars Market
1 Overview
2 Market Share Analysis, 2016
3 Competitive Scenario
3.1 Product Launches and Product Approvals
3.2 Partnerships, Collaborations, and Agreements
3.3 Acquisitions
3.4 Expansions
Contact Info:
Name: Snehal Shete
Email: Send Email
Organization: Reportsandreports
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Website: https://www.reportsnreports.com/reports/270786-biosimilars-market-product-recombinant-non-glycosylated-proteins-insulin-filgrastim-somatropin-glycosylated-monoclonal-antibodies-erythropoietin-peptides-glucagon-calcitonin-application-oncology-blood-disorders-global-forecast-to-2018.html
Source: MarketersMedia
Release ID: 499943
Pony.ai’s robotaxi fleet in the pilot zone in Nansha, Guangzhou is now accessible from Amap, the Alibaba-backed online mapping service.
We look at digital banks venturing into P2P lending in Indonesia and TikTok facing scrutiny for harming teens’ mental health.
In the next two years, Apple will focus on developing home hardware and launching a new home operating system called homeOS.
This collaboration allows users from over 10 international payment apps to make transactions with over a million merchants.
Lee Hsien Yang and sister Lee Wei Ling had accused their older brother, then PM Lee Hsien Loong, of attempting to keep the home for political capital.
The panda census methodology is widely seen as flawed, and China keeps the data shrouded in secrecy.
The funding round was led by Gulf Islamic Investments, noted for Shari’ah-compliant investing, which manages assets exceeding US$4.5 billion.
The diplomatic rift has suddenly grown more stark as Canada amplifies its accusations that India is directing lethal operations abroad.
The Singapore-based multicurrency card operator more than doubled revenue to US$30 million for FY 2024.
Many respondents feel foreign countries would come to Singapore’s aid if it were attacked, researchers find.
Khan admitted to lying repeatedly about a false anecdote involving a rape victim, raising questions about her credibility.
This week’s On the Rise looks at a Singaporean firm building small-scale models and the issues workplaces face in adopting AI
Our automated tracker can help you keep an eye on the funding activities of Japan's tech firms as they close in on the billion-dollar mark.
In an interview, East Timor’s president questions why the West wants his country to ‘do the opposite’ of the ‘whole international community’.
This IPO is poised to be the largest in India’s history and the second largest worldwide this year.
Meteorological authorities have warned of more floods that could blanket Kuala Lumpur and heavy rain in the evening.
GAC and Pony.ai have partnered since 2018, following Pony.ai's undisclosed investment in GAC's ride-hailing platform in 2022.
Customers can still scan receipts, make purchases, and convert loyalty points until Sunday.
The home at 38 Oxley Road has been the subject of a bitter family dispute between former Prime Minister Lee Hsien Loong and his two siblings.
The Indonesia-based furniture marketplace grew its revenue in 2023, but so did discounts to customers, which rose over 6x.
The destruction follows North Korea’s accusations of South Korean drones flying over its capital, Pyongyang.
The agreement supports the construction of seven small modular reactors that will produce a combined 500 MW of electricity.
Discussions are in preliminary stages, with officials noting that country-specific caps have gained traction in recent weeks.
Marco Palladino, CTO and co-founder of Kong, shares ways to optimize API infrastructure to thrive in an AI-driven world.
The use of human input raises questions over the capabilities and market readiness of the bot, despite Elon Musk’s enthusiasm.
Fundraising is hard. To make things slightly easier, we've compiled this list of fundraising startups for our subscribers.
The platform has issued over 12 million tickets annually since its 2013 launch.
The platform's user base has grown to 312 million monthly active users, a 20% increase from last year.
Officials are focused on Persian Gulf countries that have a growing appetite for AI data centres and the deep pockets to fund them.
Sirul Azhar Umar fled to Australia after the murder of Altantuya Shaariibuu, who was shot and her body blown up with explosives in 2006.
His successor Prabowo Subianto seems indifferent towards the regional bloc as well – raising concerns about Indonesia’s leadership role.
Above-average rainfall is forecast to sweep Southeast Asia over the coming months, as La Nina conditions bring storms and downpours.
The entry of TikTok Shop, Shein, and Temu is driving Southeast Asia’s cross-border merchants to overhaul their strategies.
The People's Party is less focused on personalities and party-building than on slowly shifting the perceptions of the Thai electorate.
The former World Bank director will become the first person to hold the finance portfolio under three presidential administrations.
Analysts say Russia fears Japan’s growing ties with Nato nations – and is especially concerned about US missile deployments.
Plus, an artist sues to reclaim his work.
Angry at what they view as China’s state-led xenophobia, taught in schools and prevalent online, some people are taking action, even at personal risk.
Pakistani Taliban claimed attack in which militants wearing suicide vests stormed remote police base. Police shot dead all 5 attackers.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.